Trials / Unknown
UnknownNCT02557581
cAMP Signaling and Muscle Adaptations
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The role of cAMP signaling mediated by beta2-adrenergic stimulation with agonists has been well-studied in skeletal muscles of animals. Studies in humans are scant and the scope of the present study is thus to investigate the role of cAMP signaling by beta2-adrenergic stimulation for muscle adaptations in humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No training | |
| OTHER | Endurance training | |
| OTHER | Resistance Training | |
| DRUG | Terbutaline | |
| DRUG | Clenbuterol | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2017-06-30
- Completion
- 2017-10-01
- First posted
- 2015-09-23
- Last updated
- 2017-10-26
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02557581. Inclusion in this directory is not an endorsement.